Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00261469Phase 2Completed
Phase 2, open-label, single-arm trial of topiramate in migraine, sponsored by Janssen Ortho. Primary endpoint: Proportion of migraine attacks that are pain-free two hours after triptan treatment at 2 hours. Started Apr 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00261469.